Arsenal announced today the acquisition of Accumen Inc., a leading technology-enabled provider of health system performance optimization solutions, from Accretive, LLC, a specialized investment firm based in New York.
Arsenal announces the sale of Certara, the global leader in model-informed (in silico) drug development and regulatory science, focused on optimizing drug development and improving health outcomes
TractManager, the leading provider of powerful healthcare strategic sourcing and compliance application suites announced that it has named Trace Devanny Chief Executive Officer of the company.
Arsenal announced today that its portfolio company WIRB-Copernicus Group® (WCG™), has completed a recapitalization in which Arsenal Capital Partners led an investment group, including Arsenal Capital Fund IV, MSD Capital, L.P. and other leading institutional investors, to provide WCG with additional capital to continue its successful growth.
